Nebius Group (NBIS): Assessing Valuation After Recent Share Price Volatility

Nebius Group (NBIS) has caught some attention lately as investors react to shifts in its business performance and broader market sentiment. The company’s recent swings in returns raise some intriguing questions about value and momentum going forward.

See our latest analysis for Nebius Group.

Nebius Group’s share price has been riding waves of market excitement, with a standout 228% return year-to-date and a hefty 289% total shareholder return over the past year. After an explosive multi-month climb, the recent sharp 23% drop in just 30 days shows volatility is still part of the story. Momentum remains strong in the bigger picture as the company continues to attract attention.

If rapid surges and market pivots interest you, it could be the perfect moment to broaden your search and discover fast growing stocks with high insider ownership

With Nebius Group’s shares trading well below analyst targets despite impressive revenue and profit growth, the central question is whether the stock is truly undervalued or if the market has already priced in all the upside for future gains.

Advertisement

Most Popular Narrative: 37% Undervalued

With Nebius Group’s fair value estimate of $159 well above the last close price of $100.15, the most widely followed narrative suggests there is a significant gap between current market pricing and what analysts expect. This sets up an intriguing story for those watching both the company’s momentum and valuation.

Aggressive geographic expansion, notably into key markets such as the U.K., Israel, U.S. (New Jersey), and Finland, with imminent data center launches and local partnerships, positions Nebius to diversify its customer base, tap into regional AI investment booms, and unlock new enterprise opportunities. This could positively affect top-line growth and revenue stability.

Read the complete narrative.

How bold are the assumptions fueling this lofty fair value? The narrative relies on projections that may surprise most investors tracking AI infrastructure deals. Before you accept the consensus, you may want to discover the high-octane revenue growth and recalibrated margins behind the calculations. Ready to see what is driving these figures?

Result: Fair Value of $159 (UNDERVALUED)

Have a read of the narrative in full and understand what's behind the forecasts.

However, sustained intensifying competition and potential regulatory hurdles could undermine Nebius Group's growth if expansion costs increase or market access challenges arise.

Find out about the key risks to this Nebius Group narrative.

Another View: A Look at Book Value

Stepping back from fair value estimates, let’s check Nebius Group’s value through the lens of its price-to-book ratio. At 5x, the company appears expensive against the US Software industry average of 3.4x, though it is notably cheaper than its peer group average of 10.8x. This mix of signals could point to both valuation risk and opportunity. Is the market optimistic, or simply overlooking different fundamentals?

See what the numbers say about this price — find out in our valuation breakdown.

NasdaqGS:NBIS PB Ratio as at Dec 2025
NasdaqGS:NBIS PB Ratio as at Dec 2025

Build Your Own Nebius Group Narrative

If you see things differently or want to dig into the details yourself, you can build your own story around Nebius Group in just minutes. Do it your way.

A great starting point for your Nebius Group research is our analysis highlighting 3 key rewards and 3 important warning signs that could impact your investment decision.

Looking for more investment ideas?

Smart investors never limit themselves to one company. Give yourself the edge by checking out these compelling opportunities. These picks might be exactly what your portfolio needs right now.

  • Tap into growth by accessing these 25 AI penny stocks, which are driving breakthroughs in artificial intelligence, automation, and transformative digital solutions shaping the next era of innovation.
  • Boost your income with stability through these 14 dividend stocks with yields > 3%, offering yields above 3%, perfect for those who want reliable returns alongside long-term growth potential.
  • Embrace the future of finance and technology as you explore these 81 cryptocurrency and blockchain stocks, at the forefront of the cryptocurrency and blockchain revolution.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.

Valuation is complex, but we're here to simplify it.

Discover if Nebius Group might be undervalued or overvalued with our detailed analysis, featuring fair value estimates, potential risks, dividends, insider trades, and its financial condition.

Access Free Analysis

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com

About NasdaqGS:NBIS

Nebius Group

A technology company, engages in building full-stack infrastructure to service the global AI industry in the United States, the United Kingdom, and internationally.

High growth potential with mediocre balance sheet.

Advertisement

Weekly Picks

LO
Lou_Basenese
OPTH logo
Lou_Basenese on Optimi Health ·

The Only Psychedelic Company Already Selling MDMA and Psilocybin to Real Patients, Yet Priced Like It Doesn’t Exist

Fair Value:US$1155.3% undervalued
51 users have followed this narrative
2 users have commented on this narrative
9 users have liked this narrative
BL
BlackGoat
IREN logo
BlackGoat on IREN ·

IREN's Bold Moves in Sustainable Bitcoin Mining & AI Data Centers

Fair Value:US$71.4849.2% undervalued
204 users have followed this narrative
6 users have commented on this narrative
32 users have liked this narrative
HE
HedgeY
ARM logo
HedgeY on Arm Holdings ·

The Architecture Layer of AI Computing - But Priced Like the Future Already Arrived?

Fair Value:US$43038.1% undervalued
9 users have followed this narrative
1 users have commented on this narrative
3 users have liked this narrative
HI
Hidden_Rock_Capital
FISV logo
Hidden_Rock_Capital on Fiserv ·

Temporary "perfect storm" leads to opportunity to buy financial services leader for less than 5x long-term earnings

Fair Value:US$119.9956.4% undervalued
13 users have followed this narrative
0 users have commented on this narrative
6 users have liked this narrative

Updated Narratives

ON
LOT logo
Ontological on Lotus Technology ·

Lotus Tech, Finloop and FOMO Pay Collaborate to Explore Vehicle Tokenization

Fair Value:US$2.463.9% undervalued
1 users have followed this narrative
0 users have commented on this narrative
0 users have liked this narrative
NE
AIIO logo
newsfinder11221 on Robo.ai ·

Robo.ai (NASDAQ: AIIO): Building the Infrastructure Behind the AI Revolution

Fair Value:US$540.4% undervalued
1 users have followed this narrative
3 users have commented on this narrative
0 users have liked this narrative
EU
European_Hidden_Gem_Stocks
ALMIN logo
European_Hidden_Gem_Stocks on MINT Société anonyme ·

Mint SA: A French Micro-Cap Energy Retailer Worth Watching

Fair Value:€1153.1% undervalued
1 users have followed this narrative
0 users have commented on this narrative
0 users have liked this narrative

Popular Narratives

CU
MSFT logo
CubanEros on Microsoft ·

A wonderful business at reasonable price.

Fair Value:US$419.917.3% undervalued
87 users have followed this narrative
0 users have commented on this narrative
6 users have liked this narrative
OS
oscargarcia
NVDA logo
oscargarcia on NVIDIA ·

The company that went from selling GPUs to gamers to becoming the AI arms dealer of the 21st century.

Fair Value:US$28029.8% undervalued
196 users have followed this narrative
9 users have commented on this narrative
15 users have liked this narrative
BE
PYPL logo
benjamin_lvieq on PayPal Holdings ·

PayPal: PayPal Doesn't Need to Grow – It Needs to Stop Falling – A Mispriced Cash Machine With a Cannibal Buyback

Fair Value:US$6513.7% undervalued
73 users have followed this narrative
2 users have commented on this narrative
11 users have liked this narrative

Trending Discussion

DE
TDOC logo
derek_3wsdg on Teladoc Health ·

You’ve overlooked the activist investor factor. Travis Cocke’s Voss has announced 5% ownership through a 13G filing. They’ve added to that 5% since, and in doing so, have created a structural trap door for 27.42 Million Shares actively sold short. Chuck will announce lots of positives on July 29 but it’s what Voss announces shortly after that will rock the overextended Teledoc shorts. The Walmart partnership is the tip of the iceberg. The market is missing the sheer regulatory and enterprise friction of modern corporate healthcare. Teladoc isn't a "consumer app"; it is the primary digital infrastructure integrated directly into the legacy backends of Tier-1 insurance companies and fortune 500 employers, covering 105 million+ lives. Teladoc is acting as the digital top-of-funnel engine for the world's largest retailer. If Voss pushes the narrative that Teladoc is effectively the outsourced digital brain of Walmart's entire healthcare footprint, the fair value shifts from a basic health multiple to an enterprise distribution premium. Additionally , we are in a structural gold rush for high-quality, legally compliant, longitudinal medical data to train vertical healthcare AI models. Large technology hyperscalers and pharmaceutical giants cannot simply scrape the internet for this; they need structured clinical inputs. Teladoc sits on one of the largest de-identified virtual medical datasets on earth. From the activist playbook , we’ll see Voss demand the immediate creation of a Data & Diagnostics Licensing Division, transforming a legacy liability into an incredibly high-margin, pure-software data asset that requires zero human clinician hours to scale. Chuck is doing great work and deserves credi5 for the Teledoc turnaround but it will be Travis Cocke who will be responsible for a share price way beyond your $15 valuation.

1
|
0